Cluster B
COPD and adverse effects of inhaled corticosteroids
- Inhaled Corticosteroids in patients with asthma-COPD overlap: differences in effect depending on delivery by dry powder device vs. pressurized metered-dose inhalers
- Use of inhaled corticosteroids and risk of Moraxella catarrhalis infection in patients with chronic obstructive pulmonary disease
- Inhaled Corticosteroids in Patients with Chronic Obstructive Pulmonary Disease and Risk of Acquiring Streptococcus Pneumoniae Infection
- ICS and risk of Hemophilus influenza
- Long-term use of inhaled corticosteroids and the risk of developing type 2-diabetes in COPD
- Use of ICS and risk of osteoporosis and osteoporosis related fractures in COPD patients
- Use of inhaled corticosteroids and the risk of new onset depression in COPD patients
